Evidence map›Paper›PMID 39766053›Full record

ArticleCancers2024

Endoscopic and Histological Characteristics of Gastric Cancer Detected Long After

Ryo Abe, Shu Uchikoshi, Yohei Horikawa, Nobuya Mimori, Yuhei Kato, Yuta Tahata, Saki Fushimi, Masahiro Saito, Satsuki Takahashi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ryo AbeDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Shu UchikoshiMatsuzono Second Hospital, Morioka 020-0103, Iwate, Japan.
Yohei HorikawaDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Nobuya MimoriDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Yuhei KatoDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Yuta TahataDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Saki FushimiDepartment of Gastroenterology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Masahiro SaitoDepartment of Clinicopathology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.
Satsuki TakahashiDepartment of Clinicopathology, Hiraka General Hospital, Yokote 013-8610, Akita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesSince 2013, eradication therapy for

methodOne hundred patients with differentiated cancers detected after

resultsThere was no significant difference regarding the background mucosa and tumor mucosa between the two groups. In the delayed group, the remnant rate of the fundic glands was 19.8 ± 15.6%, and IM was 87.1% (27/31). Further, 90.3% (28/31) of the patients exhibited persistent neutrophil infiltration.

conclusionThis study suggested that patients with a low remnant rate of the fundic gland and IM and persistent mucosal inflammation were at high risk for developing pE-GCs.

Indexed as

late cancerpE-GCsthe remnant rate of the fundic glands

Identifiers

PMID39766053
PMCPMC11674422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.